Case report on cycloserine serum levels after treatment with oral terizidone and oral cycloserine
Lauren Rose, Jonathan Thompson, Louise Berry, Pradhib Venkatesan
Abstract
Lauren Rose, Jonathan Thompson, Louise Berry, Pradhib Venkatesan
Abstract
A 24 year old man with multi-drug resistant pulmonary tuberculosis was treated with a regime that included terizidone and then cycloserine. Serum drug levels of cycloserine were higher on milligram equivalent doses of cycloserine. Guidance implies that terizidone should be considered bioequivalent to cycloserine, but this case illustrates that this cannot be presumed. Any reduction in neuropsychiatric side-effects with terizidone may be due to lower cycloserine exposure and thereby reduced anti-mycobacterial efficacy.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A 24 year old man with multi-drug resistant pulmonary tuberculosis was treated with a regime that included terizidone and then cycloserine. Serum drug levels of cycloserine were higher on milligram equivalent doses of cycloserine. Guidance implies that terizidone should be considered bioequivalent to cycloserine, but this case illustrates that this cannot be presumed. Any reduction in neuropsychiatric side-effects with terizidone may be due to lower cycloserine exposure and thereby reduced anti-mycobacterial efficacy.
Key concepts: Cycloserine, Pharmacology, Medicine, Drug, Internal medicine, Tuberculosis, Pathology